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Macrophages are important tissue resident cells that regulate the dynamics of inﬂammation. How-
ever, they are strikingly heterogeneous. During studies looking at podoplanin (gp38) expression on
stromal cells in the murine spleen and peritoneal cavity we unexpectedly discovered that podopla-
nin was expressed on a subset of F4/80+ macrophages; a subset which we have termed ﬁbroblastic
macrophages (FM). These cells function as phagocytes in vitro as measured by beadmediated phago-
cytosis assays. FM also exist at high frequency in the peritoneal cavity and in zymosan induced peri-
tonitis in vivo. These FM represent a unique subgroup of F4/80+ macrophages and their presence in
the inﬂamed peritoneum suggests that they play a role in zymosan induced peritonitis.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Macrophages are heterogeneous cells that are found in both
lymphoid and peripheral organs as part of the mononuclear phago-
cyte system. They are widely distributed in different anatomical
locations where they have a speciﬁc nomenclature and function.
For example alveolar macrophage are found in the lung, meningeal
macrophage in the nervous system, kupffer cells in the liver and
serosal macrophage in the peritoneal cavity [1–3]. There is even
heterogeneity within a single organ such as the spleen where
marginal zone, metallophilic, white pulp, tangible body and red
pulp macrophages have been identiﬁed [4]. Their distinct pheno-
type has been determined by surface molecules which have been
identiﬁed on different macrophages despite their overlap with
monocytes [5], dendritic cells (DC) [6] as well as macrophages
involved in the resolution of inﬂammation [7].chemical Societies. Published by E
, classic macrophages; SLO,
r cells
Research Group, School of
gulation, College of Medical
ngham B15 2TT, UK. Fax: +44
kley).Podoplanin, also known as gp38, is expressed on stromal cells in
different tissues including kidney, heart and lymphoid organs [8].
Despite the lack of a clearly deﬁned function, podoplanin has been
widely used as a stromal cell surface marker. In secondary lym-
phoid organs, podoplanin is highly expressed on ﬁbroblastic retic-
ular cells (FRC) which provide a conduit regulating the transport of
small molecules including antigens and chemokines [9].
During studies aimed at examining stromal subsets in the red
pulp of the spleen we unexpectedly discovered that podoplanin is
expressed on a subset of F4/80+ macrophages, which we have
termed ﬁbroblastic macrophages (FM). These FM are capable of
high levels of phagocytosis. In the peritoneal cavity, FM exist at a
relatively high frequency and in a model of resolving peritonitis
there are markedly more F4/80+podoplanin+ FM than at rest, with
their numbers increasing in a dose dependent manner. Our ﬁndings
suggest that FM may play a role in zymosan mediated peritonitis.
2. Methods and materials
2.1. Mice
C57BL/6. mice were housed in the animal facilities at the
University of Birmingham and University College London. All
experiments were performed in accordance with United Kingdomlsevier B.V. All rights reserved.
3956 T.Z. Hou et al. / FEBS Letters 584 (2010) 3955–3961Home Ofﬁce regulations. Mice were used between 2 and 12 weeks
of age and were sex and age matched unless otherwise indicated.
2.2. Cell preparation and culture
Spleens were minced and cells were prepared as described
[10]. Cells from the peritoneal cavity were washed out byFig. 1. Podoplanin expressing F4/80+ macrophages exist in the red pulp of spleen. Express
scan of a representative area. Scale bars represent 200 lm. (B) Highlighted area in A. H
100 lm. (C) Highlighted area in B. Scale bars represent 50 lm. (D) Highlighted area in
podoplanin along indicated cells. Results are representative of three separate experimenphosphate buffered saline (PBS). Single cell suspension was
achieved by ﬁltering through 70 lm cell strainers (BD Biosci-
ences). Cells were counted and used for culture with Dulbecco’s
Modiﬁed Eagle’s Medium with 10% FCS and 1% glutamine/penicil-
lin/streptomycin. Non-adherent cells in culture were removed by
washing.ion of B220 (blue), F4/80 (green) and podoplanin (red) onWT spleen section. (A) Tile
istogram of B a showed MFI of podoplanin on areas crossed. Scale bars represent
C. Scale bars represent 20 lm. Histograms of D a and b show MFI of F4/80 and
ts.
Fig. 2. Phenotype of F4/80+podoplanin+ FM. Expression of indicated Abs on the four
cell populations. FM: ﬁbroblastic macrophages (F4/80+, gp38+, CD11c, B220);
CM: classic macrophages (F4/80+, gp38, CD11c, B220); cDC: conventional
dendritic cells (F4/80, gp38, CD11c+, B220) and B: B cells (F4/80, gp38,
CD11c, B220+) by ﬂow cytometry. Numbers in plots indicate percentage of cells.
Data are representative of two independent experiments.
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Cultured cells were detached with disassociation buffer (GIB-
CO). Cells were incubated with anti-mouse antibodies (Supple-
mentary Table 1) at 4 C for 30 min. Cells were acquired using a
FACSCalibur or Dako Cyan ﬂow cytometer. Data were analyzed
by FlowJo software (Tree Star). For sorting, cells were stained as
above and then puriﬁed by MoFlo cell sorter (Dako Cytomation).
2.4. RNA isolation and PCR analysis
RT-PCR was performed as described [10]. Brieﬂy, puriﬁed cells
as indicated were used for obtaining mRNA and high-purity cDNA
by uMacs One-step cDNA synthesis kit (Miltenyi Biotech). b-Actin
was used as housekeeping gene prior to amplifying target gene
Podoplanin. Reactions were conducted in a Peltier Thermal
Cycler-200 (MJ Research, Genetic Research Instrumentation, UK).
PCR products were fractionated by agarose gel electrophoresis
and identiﬁed by fragment size. The primer sequences, NCBI Acces-
sion numbers and amplicon sizes are as follows:
b-Actin (NM_007393.3)
forward (50-TGGAATCCTGTGGCATCCATGAAAC-30),
reverse (50-TAAAACGCAGCTCAGTAACAGTCGG-30) 349 bp
Podoplanin (NM_010329.2)
forward (50-ACCGTGCCAGTGTTGTTCTG-30),
reverse (50-AGCACCTGTGGTTGTTATTTTGT-30) 159 bp
2.5. Immunoﬂuorescence staining and confocal microscopy
Cells were incubated with antibodies (Supplementary Table 1)
at room temperature for 30 min. Excess antibody was removed
and slides were washed in PBS. Cell nuclei were counterstained
with 40-6-diamidino-2-phenylindole (DAPI) for 1 min. Slides were
mounted with 30 ll glycerol containing 1,4-diazobicyclo (2,2,2)
octane (DABCO). Confocal images were acquired using a Zeiss
LSM 510 laser scanning confocal microscope (Carl Zeiss) and ana-
lyzed using LSM510 software.
2.6. Phagocytosis assays
FluoSpheres (Molecular Probes) were washed with RPMI media
before use. These ﬂuorescent beads were resuspended with cells
and incubated for 3 h at 37 or 0 C. Cells were imaged by phase
contrast microscopy or detached with disassociation buffer
(GIBCO) for FACS. For assays using dynabeads, cells were cultured
in glass dishes (MatTek) coated with 100 lg/ml Poly-L-lysine
(Sigma). Dynabeads coated with anti-rat IgG (Invitrogen) were
incubated with cells for 3 h at 37 C. LysoTracker (1 ll/ml) (Molec-
ular Probes) was incubated with cells for 5 min at room tempera-
ture. Cells were co-stained with antibodies (Supplementary Table
1) for 20 min and were examined by confocal microscopy.
2.7. Induction of peritonitis
Peritonitis was induced by the intraperitoneal injection (i.p.) of
either 0.1 or 10 mg type A zymosan (Sigma) as previously depicted
[11]. Peritoneal cavity washout cells were collected with PBS at
72 h post injection. Eythrocytes in the peritoneal exudate were
lysed and cells were enumerated by counting before FACS staining.
3. Results
3.1. Identiﬁcation and characterization of podoplanin+ murine FM
During studies which aimed to identify stromal cell subsets in
the red pulp of the spleen, discrete populations of VCAM-1 andF4/80 expressing cell could be observed. Compared to F4/80 which
speciﬁcally labeled the red pulp only, VCAM-1 was expressed in
both white pulp and red pulp areas (Supplementary Fig. 1(i)). F4/
80 and VCAM-1 co-localized on a subset of macrophages in the
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two macrophage/dendritic cell populations, namely F4/80+VCAM-
1+ and F4/80+VCAM-1 are present in the red pulp of the spleen.
To further characterize these two populations we dispersed
cells in the spleen and analyzed them by FACS. Consistent with
our histology ﬁndings, four subsets were identiﬁed, F4/80+VCAM-
1+, F4/80+VCAM-1, F4/80VCAM-1+ and F4/80VCAM-1 cells.
Further phenotypic analysis revealed that CD11b, CD80, CD86
and surprisingly podoplanin was expressed on both VCAM-1+Fig. 3. Enrichment of F4/80+podoplanin+ FM. Expression of CD45, F4/80 and podoplanin
indicate percentage of cells. Data are representative of three independent experiments.
Fig. 4. Phagocytosis mediated by F4/80+podoplanin+ FM. (A) Expression of beads on cultu
Cells and ﬂuorescent beads (red) were imaged by phase contrast microscopy (10)
Incorporation of beads by F4/80+ cells using confocal microscopy. Cells were incubated w
beads and F4/80+ cells were shown in blue. Intracellular beads were indicated by ar
LysoTracker (green). Internalized beads by cells (forming acidic phagosomes) were marke
of three separate experiments.and VCAM-1 splenic macrophages but not on F4/80 non-macro-
phage leucocytes (data not shown).
To conﬁrm the existence of F4/80+podoplanin+ FM in situ in the
spleen, tissue sections were examined for F4/80 and podoplanin
expression by histology (Fig. 1A). As well as being strongly ex-
pressed on FRC in the white pulp, podoplanin was also detected
on F4/80+ macrophage subsets in the red pulp but at a lower inten-
sity than on FRC (Fig. 1B). The pattern of podoplanin expression on
the F4/80+ ﬁbroblastic macrophage subpopulation was different toon cultured splenocytes by ﬂow cytometry with isotype controls. Numbers in plots
red splenocytes by ﬂow cytometry. Numbers in histogram indicates percentage. (B)
. (C) Cells and dynabeads (brown) were imaged by light microscopy (40). (D)
ith anti-rat IgG coated dynabeads and rat anti-mouse F4/80 antibody. Extracellular
rows. Scale bars represent 10 lm. (E) Cells were incubated with dynabeads and
d in ring like compartments. Scale bars represent 10 lm. Results are representative
T.Z. Hou et al. / FEBS Letters 584 (2010) 3955–3961 3959that found on FRC. Expression was more patchy and more cellular
on FM in the red pulp, whereas conduit-like structures were ob-
served on FRCs in the white pulp (Fig. 1B and C). Co-expression
of F4/80 and podoplanin was conﬁrmed at a single cell level
(Fig. 1D).
The phenotype of FM is distinct from classic macrophages (CM)
as well as typical antigen presenting cells such as dendritic cells
and B cells. FM expressed lower levels of CD86, VCAM-1 and
ICAM-1 but higher CD11b, Gr-1, Ly-6C, CD62L, CD44 and MHC-II
expression than CM (Fig. 2). To conﬁrm that podoplanin is pro-
duced by FM, mRNA for podoplanin was examined by PCR in cells
isolated by FACS sorting. Podoplanin mRNA was found in puriﬁed
FM but not CM or lymphocytes (Supplementary Fig. 2).Taken to-
gether this suggests that FM are a distinct macrophage subset with
a unique cell surface phenotype.
3.2. FM expanded in vitro mediate phagocytosis
To further explore the function of FM, we isolated and enriched
these cells from the spleen following in vitro culture as described in
materials andmethods. After enrichment by in vitro culture, almost
all CD45+F4/80+ macrophages expressed podoplanin, showing that
unlike CM, FM can be expanded and proliferate in culture (Fig. 3).
Consistent with our observations on cells in vivo, both FACS
(Fig. 3) and confocal analysis (data not shown) demonstrated that
cultured FM express CD45, F4/80 and podoplanin at a single cell
level. To determine whether F4/80+podoplanin+ FM can function
as macrophages, we performed bead mediated phagocytosis assays
in vitro. A proportion (over 40%) of enriched FM was able to
phagocytose beads (Fig. 4A). These observations were conﬁrmed
by live cell imaging with phase contrast (Fig. 4B) and light micros-
copy (Fig. 4C). To verify that the beads had been fully internalized,
we incubated FMwith anti-rat IgG coated beads and rat anti-mouse
F4/80 antibody together. The extracellular beads including both
membrane bound and free beads, bound F4/80 antibody whereas
those that had been internalized did not. Because F4/80 antibody
is not able to enter live cells with an intact membrane, intracellular
beads were not stained. Those cells that showed extensive bead up-
take also showed strong F4/80 expression (Fig. 4D).Fig. 5. Quantiﬁcation of FM mediated phagocytosis. (A) Puriﬁcation of CD45+(F4/80+) FM
Purity was typically over 99% as shown. Numbers in plots indicate percentage. (B) FM b
ﬂuorescent beads at 37, or 0 C (negative control), or beads alone (positive control). MFI
bead on FM or non-FM. *P < 0.05; **P < 0.01; ***P < 0.001. Data (mean ± S.D.) are represeTo examine the nature of the phagocytic compartment, we la-
beled the cells with the lysotracker dye which marks acidic organ-
elles. The intracellular beads were present in compartments ringed
by lysotracker demonstrating they were within acidic phagosomes
(Fig. 4E). Furthermore, both VCAM-1+ and VCAM-1 F4/80 express-
ing macrophages mediated phagocytosis (Supplementary Fig. 3).
These data collectively indicate that FM have the capacity to medi-
ate phagocytosis.
To quantify phagocytosis, FM were sorted for CD45+(F4/80+)
and CD45(F4/80) subsets (Fig. 5A), which were then tested for
bead engulfment. The majority (85.5 ± 4.6%) of CD45+ FM were
positive for bead staining compared to 25.2 ± 14.7% of CD45
non-FM. FM were able to phagocytose over 7 beads per cell
whereas F4/80 podoplanin+ cells (non-FM) were only able to en-
gulf one bead or less in a temperature sensitive manner (Fig. 5B).
Furthermore, the MFI of engulfed beads in FM was signiﬁcantly
higher than in non-FM and controls (Fig. 5C). This further supports
our ﬁndings that F4/80+podoplanin+ FM can function as efﬁcient
phagocytic cells.
3.3. Existence of FM in the peritoneal cavity in vivo
To examine whether F4/80+podoplanin+ FM exist in vivo, we
examined the expression of F4/80 and podoplanin on peritoneal
cells following a zymosan challenge. Results showed that in both
naïve and mice immunized with 0.1 and 10 mg zymosan, a signif-
icant population of peritoneal cells expressed both F4/80 and
podoplanin in the peritoneal exudate. F4/80+podoplanin+ FM co-
existed with F4/80+podoplanin- (CM) macrophages in the perito-
neal cavity (Fig. 6A(i)). FM were larger in size than CM. These
differences were observed in both non-immunized and immunized
animals (Fig. 6A(ii)). Therefore it is possible to differentiate FM
from CM by their distinct cellular proﬁles as well as expression
of podoplanin (Supplementary Fig. 4). These in vivo ﬁndings
suggest that F4/80+podoplanin+ FM are likely to be a biologically
relevant population of cells. The percentage of FM in immunized
mice was markedly higher than those in naïve mice and increased
with increasing dose of zymozan, whereas the percentage of CM
remained stable (Fig. 6B).and CD45(F4/80) non-FM from cultured splenocytes by ﬂow cytometric sorting.
ut not non-FM splenocytes phagocytosed in high level. Cells were incubated with
of phagocytosis were analyzed and shown in histogram. (C) Quantitative analysis of
ntative of three independent experiments.
3960 T.Z. Hou et al. / FEBS Letters 584 (2010) 3955–3961To directly compare the phagocytic ability of peritoneal FM and
CM their abilities to uptake beads were determined. Surprisingly
FM phagocytosed signiﬁcantly more beads than CM did in a tem-
perature sensitive manner (Supplementary Fig. 5). Taken together,
our data support the concept that FM are a highly phagocytic novel
cell population whose number increase signiﬁcantly during perito-
neal inﬂammation induced by zymosan.
4. Discussion
The heterogeneity of macrophages has long been recognized
with local microenvironments impacting on the phenotype and
function of tissue resident macrophage subsets [1]. However, theFig. 6. Existence of F4/80+podoplanin+ FM in peritoneal cavity in vivo. (A) Percentage of F
in a peritonitis model. (ii) Forward and side scatter proﬁle of highlighted popula
80+podoplanin+CD45+ (FM) and F4/80podoplanin-CD45+ (Others) cells were compared a
zymosan) peritonitis at 72 h post injection. Data are representative of three independenrelationship between resident macrophages and local stromal cells
(such as ﬁbroblasts) in terms of whether they share any overlap-
ping phenotype and function has not been extensively explored.
Although podoplanin expression on stromal FRC in lymphoid or-
gans has been reported [8], its expression on hematopoietic
(CD45+) cells has not been fully explored. We have demonstrated
that F4/80+ macrophages in the spleen and peritoneum express
podoplanin both in vitro and in vivo. Since the expression pattern
and intensity of podoplanin on FRC and FM were distinctive, our
results suggest that the function of podoplanin on FM may be dif-
ferent from that on FRC.
Our discovery of podoplanin expression on F4/80+ macro-
phages in spleen and peritoneum, using both FACS and histology,4/80+podoplanin+ and F4/80+podoplaninmacrophages among total peritoneal cells
tions (a–f) from (i). (B) The percentage of F4/80+podoplaninCD45+ (CM), F4/
mong naïve (0 mg zymosan), resolving (0.1 mg zymosan) and non-resolving (10 mg
t experiments.
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CD11b+podoplanin+ macrophages have been previously described
in peritoneal exudates cells, where it was suggested that they
play a role in lymphangiogenesis but their ability to mediate
phagocytosis was not explored [12]. Our ﬁndings suggest that
podoplanin is more widely expressed in the immune system
than has so far been appreciated. Podoplanin/ mice exhibit
embryonic lethality, due to respiratory failure [13] and cardiac
malformations [14] as well as defects in lymphatic vessel
formation [15]. However, a deﬁnitive function for podoplanin
remains elusive. We hypothesize that podoplanin expressed on
FM directly binds to and present small molecules including
chemokines and regulate lymphocytes recruitment and migra-
tion and therefore the dynamics of cellular complex in inﬂam-
mation. This idea is consistent with the ﬁnding that
podoplanin and CCL21 proteins colocalize in vivo and the bind-
ing of recombinant human podoplanin to CCL21 is a high-afﬁnity
interaction [16].
Stromal macrophages (SM), as opposed to CM in bone marrow
[17] have been reported over a decade ago. However, the expres-
sion of podoplanin was not explored in these studies. The inﬁltra-
tion of SM into cancer sites suggest these cells are able to migrate
in response to chemoattractive clues [18,19]. Most recently, using
bone marrow cell line [20] a critical function of IRF-7 in stromal
macrophages to control intracellular Leishmania donovani has been
described. The cells have also been characterized by gene expres-
sion proﬁling in response to infection [21].
Macrophages are mononuclear phagocytes which are indis-
pensable for an efﬁcient innate and acquired immune response
[5]. We have found that F4/80+podoplanin+ FM function as mac-
rophages and mediate high levels of phagocytosis in vitro. We
suggest that these FM might be responsible for the removal of
old/damaged platelets, aged erythrocytes and apoptotic cells
in vivo [22]. Classical (M1) [23], non-classical (M2) including
alternative or wound healing and regulatory [2], and resolu-
tion-phase macrophages (rM) [24] have all been described.
Whether FM represent a new distinctive population or a subpop-
ulation of previous described macrophages remains to be
explored. In addition whether the increase in FM after zymosan
immunization is due to self-renewal, recruitment from blood
borne precursor and further differentiation into peritoneal mac-
rophages remains to be addressed. We speculate that FM pro-
mote the resolution of acute inﬂammation by supporting the
clearance of pro-inﬂammatory leucocytes by phagocytosis. Our
studies expand our knowledge of the subsets of macrophages
to include CM, SM and FM. Further studies will be needed to
map the relationship between these distinct but functionally
related cells.Acknowledgements
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